Harijati Versmessen

Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial

Samuel Bral, Thierry Gevaert, Nadine Linthout et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 181 citations

Adaptive Radiotherapy, Radiation Medicine, Phase Ii Trial +9

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

Darius Norkus, Agata Karklelyte, Benedikt Engels et al. · Radiation Oncology · 2013 · 59 citations · Full text

Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy

Harijati Versmessen, Vincent Vinh‐Hung, Hilde Van Parijs et al. · BMC Cancer · 2012 · 51 citations · Full text

Toxicity and Outcome Results of a Class Solution With Moderately Hypofractionated Radiotherapy in Inoperable Stage III Non–Small Cell Lung Cancer Using Helical Tomotherapy

Samuel Bral, Michaël Duchateau, Harijati Versmessen et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 36 citations

Moderately Hypofractionated Radiotherapy, Radiation Medicine, Radiation Therapy +9

Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy

Nele Adriaenssens, Mark De Ridder, Pierre Lievens et al. · World Journal of Surgical Oncology · 2012 · 26 citations · Full text